Since CCL5 is induced in ADR-treated podocytes, similar to Notch2 activation, we investigated whether CCL5 plays a protective role in ADR-induced nephropathy by assessing podocyte apoptosis. The gene discussed is CCL5; the disease is kidney disorder.